Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
MedTech Stocks to Watch for Earnings on Aug 3
05:13pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
MedTech players are likely to have benefited from the consistent opening of economies and sales contributions from high testing demand. Let's see how CRL, CVS, BRKR and NUVA fare this time.
This Stock Is Up 30% in 1 Month, With More Upside Ahead
02:45pm, Tuesday, 02'nd Aug 2022 The Motley Fool
What stock soars 30% in this market? Hims & Hers.
What To Expect From CVS Health's Q2?
12:00pm, Tuesday, 02'nd Aug 2022
We expect CVS stock to trade higher post the results announcement, with Q2 revenue and earnings likely being above the consensus estimates, primarily driven by the post-pandemic recovery in the retail
3 Health Care Stocks in Great Financial Health
11:46am, Tuesday, 02'nd Aug 2022
Health care's potential to do better in both up and down markets makes it a valuable part of a long-term investment strategy.
This Stock Is Up 30% in 1 Month, With More Upside Ahead
10:45am, Tuesday, 02'nd Aug 2022
What stock soars 30% in this market? Hims & Hers.
CVS Health Q2 Preview: Can the Earnings Streak Continue?
09:35pm, Monday, 01'st Aug 2022 Zacks Investment Research
Bottom-line beats are the name of the game for CVS; the company hasn't reported quarterly EPS below the Zacks Consensus EPS Estimate since 2015.
CVS Health Q2 Preview: Can the Earnings Streak Continue?
07:23pm, Monday, 01'st Aug 2022
Bottom-line beats are the name of the game for CVS; the company hasn't reported quarterly EPS below the Zacks Consensus EPS Estimate since 2015.
Rite Aid (RAD) Moves 7.9% Higher: Will This Strength Last?
05:12pm, Monday, 01'st Aug 2022 Zacks Investment Research
Rite Aid (RAD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CVS Health (CVS) to Report Q2 Earnings: What's in the Cards?
03:26pm, Monday, 01'st Aug 2022 Zacks Investment Research
Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.
7 Undervalued High-Growth Stocks to Buy Now
07:30am, Sunday, 31'st Jul 2022
When markets panic-sell, individual investors typically abandon undervalued high-growth stocks, too. They lump inexpensive companies along with the overpriced ones.
Should CVS Health Be in Your Portfolio?
05:31am, Friday, 29'th Jul 2022
CVS has attracted some controversy recently with lawsuits and product recalls. Still, there are reasons to remain bullish about this stock, as we'll explore.
10 Biggest Companies Reporting Q2 Earnings Next Week
05:12am, Friday, 29'th Jul 2022 Investing.com
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
09:45pm, Thursday, 28'th Jul 2022 Zacks Investment Research
In the latest trading session, CVS Health (CVS) closed at $95.53, marking a -0.35% move from the previous day.
New York Attorney General sues CVS Health for violating antitrust laws
12:03pm, Thursday, 28'th Jul 2022
The New York Attorney General on Thursday sued CVS Health Corp, saying the pharmacy chain violated antitrust laws and hurt New York safety-net hospitals and healthcare providers.
Laxatives sold at CVS, Walgreens recalled due to contamination
03:10pm, Wednesday, 27'th Jul 2022
The product – distributed nationwide to wholesale and retailer outlets such as CVS, Kroger, Walgreens, Harris Teeter, Rite Aid and Walmart – is used for relief of occasional constipation.
